The interaction of vascular stiffness and cardiovascular events in women: Insights from the heart and estrogen/progestin replacement study

Chest

Volumn 127, Issue 5, 2005, Pages 1477-1480

  Ventura, Hector O ^a,b   Mehra, Mandeep R ^a,b  

^a Ochsner Clinic Foundation ^*

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DESOGESTREL; ESTRADIOL; ESTROGEN; PLACEBO; PROGESTERONE DERIVATIVE; PROGESTIN MEDROXYPROGESTERONE; UNCLASSIFIED DRUG;

BLOOD VESSEL FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; EDITORIAL; FOLLOW UP; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD PRESSURE; BLOOD VESSEL; ELASTICITY; ESTROGEN THERAPY; FEMALE; NOTE; PATHOLOGY; PATHOPHYSIOLOGY;

BLOOD PRESSURE; BLOOD VESSELS; CORONARY DISEASE; ELASTICITY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS;

EID: 19844378629     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.5.1477     Document Type: Editorial

References (26)

1. Dubey R, Imthurm B, Zacharia L, et al. Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here? Hypertension 2004; 44:789-795
2. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998; 280:605-613
3. Grady D, Applegate W, Bush T, et al. Heart and Estrogen/Progestin Replacement Study (HERS): design, methods, and baseline characteristics. Control Clin Trials 1998; 19:314-335
4. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 2002; 288:49-57
5. Bibbins-Domingo K, Lin F, Vittinghoff E, et al. Predictors of heart failure among women with coronary disease. Circulation 2004; 110:1424-1430
6. Mahomed FA. The physiology and clinical use of the sphygmograph. Med Times Gazette (Lond) 1872; 1:62-65
7. Mahomed FA. The etiology of Bright's disease and the prealbuminuric stage. Med Chir Trans 1874; 57:197-228
8. O'Rourke MF. Arterial stiffness and hypertension. In: Izzo JL, Black HR, eds. Hypertension primer: the essentials of high blood pressure, 2nd ed. Baltimore, MD: Lippincott, Williams, and Wilkins, 1999; 160-162
9. Franklin SS, Khan SA, Wong ND, et al. The importance of pulse pressure and systolic blood pressure in predicting coronary heart disease in older adults: The Framingham Study. Circulation 1999; 100:354-360
10. O'Rourke MF. Isolated systolic hypertension, pulse pressure, and arterial stiffness as risks for cardiovascular disease. Curr Hypertens Rep 1999; 3:204-211
11. Smulyan H, Safar ME. Systolic blood pressure revisited. J Am Coll Cardiol 1997; 29:1407-1413
12. O'Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness: definitions and reference values. Am J Hypertens 2002; 15:426-444
13. Ventura H, Messerli FH, Oigman W, et al. Impaired systemic arterial compliance in borderline hypertension. Am Heart J 1984; 108:132-136
14. Wang YX, Fitch RM. Vascular stiffness: measurements, mechanisms and implications. Curr Vasc Pharmacol 2004; 2:379-384
15. Madhavan S, Ooi WL, Cohen H, et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23:395-401
16. Fang J, Madhavan S, Cohen H, et al. Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens 1995; 13:413-419
17. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30:1410-1415
18. Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281:634-639
19. Miura K, Dyer AR, Greenland P, et al. Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: the Chicago Heart Association Detection Project in Industry Study. Hypertension 2001; 38:232-237
20. Antikainen RL, Jousilahti P, Vanhanen H, et al. Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure. J Hypertens 2000; 18:417-423
21. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913
22. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, et al. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002; 16:509-516
23. Miura S, Tanaka E, Mori A, et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 2003; 45:293-298
24. Teede HJ, Liang YL, Kotsopoulos D, et al. Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function. Climacteric 2002; 5:160-169
25. Westendorp IC, de Kleijn MJ, Bots ML, et al. The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial. Atherosclerosis 2000; 152:149-157
26. Schiffrin EL. Vascular stiffening and arterial compliance: implications for systolic blood pressure. Am J Hypertens 2004; 17:S39-S48